Atlas Trials

Double-blind, Randomized, Vehicle- and Comparator-controlled, Multi-center Trial to Evaluate the Efficacy and Safety of LAS41007 in the Treatment of Actinic Keratosis

Clinical trial NCT01265602 · COMPLETED

Trial details

NCT number
NCT01265602
Sponsor
Almirall, S.A.
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Actinic Keratosis
Start date
2010-11-01
Primary completion
2012-03-01
Enrollment
889

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.